Bedaquiline and Repurposed Drugs for Fluoroquinolone-Resistant Multidrug-Resistant Tuberculosis: How Much Better Are They? - Archive ouverte HAL Access content directly
Journal Articles American Journal of Respiratory and Critical Care Medicine Year : 2018

Bedaquiline and Repurposed Drugs for Fluoroquinolone-Resistant Multidrug-Resistant Tuberculosis: How Much Better Are They?

Fichier principal
Vignette du fichier
Manuscript review R2 track change.pdf (564.16 Ko) Télécharger le fichier
Origin : Files produced by the author(s)

Dates and versions

hal-03127733 , version 1 (22-12-2022)

Identifiers

Cite

Mathieu Bastard, Lorenzo Guglielmetti, Helena Huerga, Armen Hayrapetyan, Naira Khachatryan, et al.. Bedaquiline and Repurposed Drugs for Fluoroquinolone-Resistant Multidrug-Resistant Tuberculosis: How Much Better Are They?. American Journal of Respiratory and Critical Care Medicine, 2018, 198 (9), pp.1228-1231. ⟨10.1164/rccm.201801-0019LE⟩. ⟨hal-03127733⟩
8 View
1 Download

Altmetric

Share

Gmail Facebook Twitter LinkedIn More